FREE SHIPPING ON ORDERS OVER $150

melanotic macule lip treatment Mystery behind labial and oral macules: Clinical, dermoscopic and pathological aspects of Laugier-Hunziker syndrome melanotic macule lip treatment oral

$20.56

Quantity
- +
Description

SCAD was initially thought to produce severe problems including progressive muscle weakness, hypotonia, acidemia, developmental delay, and even early death

melanotic macule lip treatment Mystery behind labial and oral macules: Clinical, dermoscopic and pathological aspects of Laugier-Hunziker syndrome melanotic macule lip treatment oral

(PubMed) Zhang Y, Chen J, Qiu J, Li Y, Wang J, Jiao J

melanotic macule lip treatment Mystery behind labial and oral macules: Clinical, dermoscopic and pathological aspects of Laugier-Hunziker syndrome melanotic macule lip treatment oral

These include a number of organic acidemias, defects of fatty acid oxidation and of the carnitine cycle (such as very long chain acyl-CoA dehydrogenase (VLCAD), medium chain acyl-CoA dehydrogenase (MCAD), long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD), carnitine palmitoyltransferase 2 (CPT-2), and carnitine-acylcarnitine translocase (CACT) deficiencies)

melanotic macule lip treatment Mystery behind labial and oral macules: Clinical, dermoscopic and pathological aspects of Laugier-Hunziker syndrome melanotic macule lip treatment oral

doi: 10.1002/cbin.10955 159 NguyenKTSethAKHongSJGeringerMRXiePLeungKPet al

melanotic macule lip treatment Mystery behind labial and oral macules: Clinical, dermoscopic and pathological aspects of Laugier-Hunziker syndrome melanotic macule lip treatment oral

You may also like

recommand products